The present invention relates to the use of dendrimers with monophosphonic or bisphosphonic terminations in order to stimulate the growth of cell cultures or to activate cells in culture.
-
Page/Page column 87
(2009/06/27)
Structural Evolution and Pharmacology of a Novel Series of Triacid Angiotensin II Receptor Antagonists
cis-4-(4-Phenoxy)-1--1H-imidazol-1-yl>octyl>-L-proline derivatives represent a novel class of potent nonpeptide angiotensin II (Ang II) receptor antagonists.These compounds evolved from directed structure-activity rel
Palkowitz, Alan D.,Steinberg, Mitchell I.,Thrasher, K. Jeff,Reel, Jon K.,Hauser, Kenneth L.,et al.
p. 4508 - 4521
(2007/10/02)
Immonium salts and derivatives thereof
There are provided: novel aryloxy immonium salts, prepared by the reaction of their corresponding haloformates with amides; and phenolic compositions corresponding to the aryloxy immonium salts. These novel aryloxy immonium salts and their corresponding phenolic compositions have utility as chemical intermediates, antioxidants, stabilizers and antibacterials.
-
(2008/06/13)
More Articles about upstream products of 68997-88-6